Patents Assigned to OSIVAX SAS
  • Influenza nucleoprotein vaccines
    Patent number: 9963490
    Abstract: The present invention is related to a fusion protein comprising a variant of a nucleoprotein antigen from Influenza strain A, B or C, and a variant of a C4bp oligomerization domain for increasing the cellular immunogenicity of the nucleoprotein antigen from Influenza. The invention is also related to nucleic acids, vectors, fusion proteins and immunogenic compositions, for their use as a vaccine or immunotherapy for the prevention and treatment of influenza disease.
    Type: Grant
    Filed: December 21, 2015
    Date of Patent: May 8, 2018
    Assignee: OSIVAX SAS
    Inventors: Judith Del Campo Ascarateil, Fergal Hill